1533426-08-2Relevant academic research and scientific papers
Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: Hints for collateral sensitivity
Niso, Mauro,Abate, Carmen,Contino, Marialessandra,Ferorelli, Savina,Azzariti, Amalia,Perrone, Roberto,Colabufo, Nicola Antonio,Berardi, Francesco
, p. 2026 - 2035 (2014/01/06)
With the aim of contributing to the development of novel antitumor agents, high-affinity σ2 receptor agonists were developed, with 6,7-dimethoxy-2-[4-[1-(4-fluorophenyl)-1H-indol-3-yl]butyl]-1,2,3, 4-tetrahydroisoquinoline (15) and 9-[4-(6,7-di
